Variable 18F-fluorodeoxyglucose uptake in gastric cancer is associated with different levels of GLUT-1 expression
- 1 June 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Nuclear Medicine Communications
- Vol. 31 (6), 532-538
- https://doi.org/10.1097/mnm.0b013e32833823ac
Abstract
Detection rates of gastric cancer in F-fluorodeoxyglucose (FDG)-PET depend on the histopathological characteristics of the primary tumor. To clarify this observation, FDG uptake in gastric carcinoma was analyzed by focusing on histopathology and on the expression of the glucose transporter (GLUT-1) in the primary tumor. Thirty-five patients with the diagnosis of gastric cancer underwent FDG-PET with visual image analysis and measurement of maximum standardized uptake value (SUV(max)) before surgical treatment. Resected tumor samples were categorized according to Union internationale contre le cancer, WHO, and Laurén classification and tumor differentiation. GLUT-1 expression was graded semiquantitatively by immunohistochemistry. Statistical analysis was done for the correlation of histology, different classifications, and tumor grading with SUV(max) and GLUT-1 expression. SUV(max) significantly correlated with histopathological classifications according to the WHO (P=0.009) and Laurén classification (P=0.034). Signet-ring cell carcinoma had a median SUV(max) of only 3.0 (range, 1.0-11.5). Median SUV(max) for papillary and tubular carcinoma was 7.8 (range, 1.8-14.4). In 21 (60%) cases, GLUT-1 expression in the primary tumor was positive. GLUT-1 expression correlated significantly with tumor differentiation (P=0.018) and the classification according to Laurén (P=0.023) and WHO (P<0.001). Thirteen (76%) of 17 signet-ring cell carcinoma cases did not show any GLUT-1 expression. SUV(max) in relation to GLUT-1 expression showed a significant correlation (P=0.002). For cases with detectable GLUT-1 expression the median SUV(max) was 6.9 (range, 2.3-14.1) versus a median of 3.1 (range, 1-8.8) for cases without GLUT-1 expression. FDG uptake in gastric cancer depends on GLUT-1 expression. One major reason for low FDG uptake in signet-ring cell carcinoma is the low GLUT-1 expression in this histological subtype of gastric cancer.Keywords
This publication has 32 references indexed in Scilit:
- Einfluss von Alter und Begleiterkrankungen auf die Prognose von Patienten mit operiertem MagenkarzinomZentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie, 2009
- Imaging in Local Staging of Gastric Cancer: A Systematic ReviewJournal of Clinical Oncology, 2007
- Improvement in preoperative staging of gastric adenocarcinoma with positron emission tomographyCancer, 2005
- Current status of surgery for gastric cancer: a reviewGastric Cancer, 2005
- Diagnostik, Staging und Therapie des MagenkarzinomsZeitschrift für Gastroenterologie, 2004
- New Concepts of Staging in Gastrointestinal Tumors as a Basis of Diagnosis and Multimodal TherapyOncology Research and Treatment, 2004
- Survival in Stomach Cancer Is ImprovingAnnals of Surgery, 1999
- Staging of gastric cancer: correlation of lymph node size and metastatic infiltration.American Journal of Roentgenology, 1999
- Relevant Prognostic Factors in Gastric CancerAnnals of Surgery, 1998
- Results of Surgery on 6589 Gastric Cancer Patients and Immunochemosurgery as the Best Treatment of Advanced Gastric CancerAnnals of Surgery, 1992